Pieris Pharmaceuticals, Inc.
PIRS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,345 | -$15,120 | -$8,185 | -$6,065 |
| Dep. & Amort. | $0 | $0 | $0 | $30 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,790 | $2,381 | $1,094 | -$393 |
| Change in WC | -$165 | -$425 | $0 | $0 |
| Other Non-Cash | $1,842 | $2,064 | $323 | $3,918 |
| Operating Cash Flow | -$7,878 | -$11,100 | -$6,768 | -$2,510 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | -$9,000 |
| Other Inv. Act. | $0 | $0 | $0 | -$2,318 |
| Investing Cash Flow | $0 | $0 | $0 | -$11,318 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$416 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $242 | -$853 | -$1,202 | $87,089 |
| Financing Cash Flow | $242 | -$853 | -$1,202 | $87,089 |
| Forex Effect | $770 | -$114 | -$6 | $1,024 |
| Net Chg. in Cash | -$6,866 | $64,185 | -$7,976 | $64,239 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $70,433 | $6,248 | $83,602 | $19,363 |
| End Cash | $63,567 | $70,433 | $75,626 | $83,602 |
| Free Cash Flow | -$7,878 | -$11,100 | -$6,768 | -$2,510 |